Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in South Korea / NCT04782284
Recruiting Not applicable

Comprehensive Swallowing Rehabilitation in Patients With MSA

NCT04782284 · tracked via the Priya Life Science South Korea tracker
Sponsor
Seoul National University Hospital
Phase
Not applicable
Started
2021-05-17
Last updated
2026-04-27

Condition(s) studied

Multiple System Atrophy

Investigational drug(s) / intervention(s)

Comprehensive swallowing rehabilitationSwallowing education

Comprehensive swallowing rehabilitation: The treatment time per session is 30 minutes. Total 12 sessions are provided for 6 weeks.

Swallowing education: The education is 30 minutes. Total 1 session is provided immediately after baseline evaluation.

Study summary

The purpose of this study is to investigate the effect of comprehensive swallowing rehabilitation in patients with multiple system atrophy.

Eligibility

Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age \>19 years * Clinically diagnosed with MSA according to the guidelines of the 2nd consensus of the Gilman criteria * Clinically diagnosed to have dysphagia by a physiatrist * Two or more points on the Penetration-aspiration scale (PAS) from the Videofluoroscopic swallowing study (VFSS) conducted within 3 months Exclusion Criteria: * Moderate to severe cognitive dysfunction with Mini-mental State Examination score \< 19 * Comorbidities or structural abnormalities that may affect swallowing function * Other comorbidities that make it difficult to participate in the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Seoul National University Hospital Seoul South Korea Recruiting

More Seoul National University Hospital trials in South Korea

Effectiveness of Intraoperative Neuromonitoring of External Branch of Superior Laryngeal Nerve in Thyroid Surgery Recruiting
Implementation of the ERAS in Colorectal Cancer Patients: a Single Arm Study Enrolling by invitation
The Second Try During Landmark Approach of the Internal Jugular Vein: an Ultrasonographic Prelocation Study Starting soon
Preperitoneal Analgesia Versus Epidural Analgesia After Open Pancreaticoduodenectomy Active, not recruiting
Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study Starting soon

Other trials for the same condition

A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA) Active, not recruiting
Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04782284 on ClinicalTrials.gov ↗ ← All trials in South Korea